Page last updated: 2024-10-24

carmustine and Animal Mammary Carcinoma

carmustine has been researched along with Animal Mammary Carcinoma in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research Excerpts

ExcerptRelevanceReference
"Treatment with lonidamine increased the cytotoxicity of each drug by 1."1.28Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. ( Epelbaum, R; Frei, E; Herman, TS; Holden, SA; Liu, SD; Teicher, BA, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teicher, BA1
Herman, TS1
Holden, SA1
Epelbaum, R1
Liu, SD1
Frei, E1

Other Studies

1 other study available for carmustine and Animal Mammary Carcinoma

ArticleYear
Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Cancer research, 1991, Feb-01, Volume: 51, Issue:3

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Carmustine; Drug Resistance; Drug Scr

1991